Brendan Teehan, EVP, COO, HEAD OF COMMERCIAL at ACADIA PHARMACEUTICALS INC (ACAD), sold 2,568 shares at $17.87 ($46K) on 2024-04-08, disclosed to the SEC on 2024-04-09.
Scheduled sale ($46k) by EVP, COO, HEAD OF COMMERCIAL under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| ACAD | SELL | 2024-05-03 | $118K | — | Filing → |
| ACAD | SELL | 2024-03-27 | $184K | — | Filing → |
| ACAD | SELL | 2024-02-27 | $15K | — | Filing → |